News | Radiation Therapy | September 19, 2017

Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting

Automated processes and actionable analytics help enhance patient care, increase productivity and reduce costs through easy-to-use operational dashboards and visual reports

Elekta to Highlight MOSAIQ Oncology Analytics at ASTRO Annual Meeting

September 19, 2017 — Elekta will highlight its Mosaiq Oncology Analytics (MOA) software solution at the American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 24-27 in San Diego. MOA maximizes an electronic health record’s (EHR’s) potential to ensure clinics run at peak efficiency. MOA works seamlessly with single and multiple Mosaiq oncology information systems, either with Elekta Cloud Solutions or on premises, providing the actionable practice information needed to quickly assess and adapt to issues affecting quality of care, productivity and cost.

Elekta works with customers to tailor and validate the MOA dashboard to their specific needs, according to Andrew Wilson, vice president of global marketing for software solutions. Each MOA package is implemented so that it automatically pulls all the data that a specific client requires.

Other key benefits of MOSAIQ Oncology Analytics include:

  • Critical actionable information to help improve care for cancer patients, ensuring timely access to treatment by reducing wait times, eliminating bottlenecks and improving workflows; and
  • Efficient analysis of treatment patterns based on a variety of diagnostic indicators. These analyses readily identify trends and best practices that have the potential to improve patient outcomes. Periodic reviews of planned treatment doses, treatment plan variations, toxicity and survival help to enhance treatment efficacy.

ASTRO attendees are invited to visit Elekta to learn more about other new innovations and advanced technologies, including:

  • Magnetic resonance/radiation therapy (MR/RT), a new approach to radiation therapy in which magnetic resonance imaging (MRI) images are captured either prior to or during the fraction being delivered. Visualization of tumor position, shape, biology and surrounding tissue during radiation delivery may enable targeted adaption of the cancer treatment in real time, enabling critical advances in safety and efficacy. New technology will be presented that provides clinicians the ability to ‘see while you treat’ that may enable reductions in treatment margins around the tumor and thereby spare more healthy tissue. It may also allow clinicians to deliver a higher dose of radiation per fraction to the tumor, which may improve cancer treatment regimens and the efficiency of delivering radiation oncology care;
  • Leksell Gamma Knife Icon, which offers high-definition (HD) motion management and stereotactic cone beam computed tomography (CBCT) imaging allowing for precision intracranial radiosurgery with online dose adaptation, while also supporting instantaneous clinical decision-making and flexibility for frame-based and frameless immobilization;
  • High-definition dynamic radiosurgery (HDRS), a capability leveraging the core strengths of Versa HD linear accelerator and Monaco treatment planning system. Versa HD combines HDRS treatment capabilities and precision radiotherapy in a single platform, offering precision and speed to deliver stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments throughout the body in standard treatment time slots. Monaco powers more efficient high-definition planning with true Monte Carlo accuracy and advanced multi-criterial optimization; and
  • Elekta’s image-guided adaptive brachytherapy applicators and unified treatment planning and delivery platforms. This includes Venezia, a new gynecologic brachytherapy applicator designed to treat advanced cervical cancer, including disease with extra-cervical spread such as the parametrium and vagina.

For more information: www.elekta.com

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...
Nuance Launches Cloud-Based mPower Clinical Analytics Platform at AHRA 2018
Technology | Analytics Software | August 16, 2018
At the Association for Medical Imaging Management (AHRA) 2018 Annual Meeting and Exposition, July 22-25 in Orlando, Fla...